Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Solu Therapeutics Platform Company that develops antibody-based medicines using a degradable warhead.
Persist AI is a biotechnology company that builds long-acting microsphere formulations.
Ampersand Biomedicines is a multi-product platform that develops programmable medicines that target disease sites precisely.
Orbis Medicines is a novel macrocyclic chemistry and computational platform for oral macrocycle drug discovery.
Revisto is a pioneer AI-powered technology that simplifies the medical, legal, and regulatory review process for pharmaceutical marketing.
TRex Bio is a biotechnology company that treats diseases like cancer, fibrotic by studying human tissues.
Amprion is a biotech company that focuses on the diagnosis for brain diseases.
Basys.ai automates the process of prior authorization and utilization management for health plans/payers using an AI-based platform.
NanoSyrinx is a discovery stage biotechnology company based at the University of Warwick's Medical School.
Superluminal Medicines is a generative biological and chemical company that innovates drug discovery and development processes.
OrsoBio is a clinical-stage biopharmaceutical company that develops therapies to treat severe metabolic disorders.
RetiSpec is a medical imaging startup developing an eye scanner for early detection of Alzheimer's Disease pathology.
Myricx Bio is a biotechnology company that develops novel NMT inhibitor payloads for ADCs to treat cancer.
Vanqua Bio is a biotechnology company that discovers and develops next-generation medicines for patients with neurodegenerative diseases.
Radar Therapeutics pioneer in treatment modality, precision-expressed mRNA-based therapeutics.
Firefly Bio specializes in Degrader Antibody Conjugates (DACs) which combine the unique strengths of ADCs with selective protein degraders.
Prism is a biotechnology company that develops therapeutic drugs that cure intractable diseases using unique peptide mimic technology.
GenEdit develops next generation therapeutics for genetic diseases through safe and efficient CRISPR/Cas9 delivery.
Mariana Oncology is a biotechnology research industry.
Nido Biosciences is a clinical-stage company that develops precision medicines for severe neurological diseases.
DiogenX is a preclinical stage biotech company specializing in the development of pancreatic beta-cell modulators.
InduPro deevlops proximity-based protein therapeutics that modulate cell-surface protein interactions to treat disease.
Terns Pharmaceuticals develops small-molecule therapies for chronic diseases including cancer, metabolic disorders, and liver conditions.
Sanegene Bio develops an RNAi drug discovery platform designed for unmet clinical needs.
Eli Lilly has invested in 163 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Eli Lilly's top investment sectors include Biotechnology, Medical, Therapeutics, Health Care, Biopharma. The firm invests across 19 different industry categories.
Among tracked funding rounds, Terns Pharmaceuticals received $650.0M in a Post-IPO Equity round. Eli Lilly's total known invested capital is $13.0B.
Eli Lilly's average investment size is $96.7M across its portfolio of 163 companies.
Recent Eli Lilly portfolio additions include Solu Therapeutics, Persist AI, Ampersand Biomedicines, Orbis Medicines, Revisto. These companies were founded in 2020 or later.